𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Up-to-date on parathyroid carcinoma: Analysis of an experience of 19 cases

✍ Scribed by Maurizio Iacobone; Franco Lumachi; Gennaro Favia


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
75 KB
Volume
88
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prognosis of unresectable hepatocellular
✍ Yuka Akashi; Chizu Koreeda; Shigeki Enomoto; Shozo Uchiyama; Takako Mizuno; Yasu πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 649 KB

A multivariate analysis of data from 90 patients with unresectable hepatocellular carcinoma was performed using Cox's regression model to identify factors possibly affecting their prognoses. Thirty-one patients underwent arterial anticancer chemotherapy, and the remaining 59 patients received transc

On the use of bayesian probability theor
✍ Jeffrey J. Neil; G. Larry Bretthorst πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 628 KB

## Abstract Traditionally, the method of nonlinear least squares (NLLS) analysis has been used to estimate the parameters obtained from exponential decay data. In this study, we evaluated the use of Bayesian probability theory to analyze such data; specifically, that resulting from intravoxel incoh

Benefit of initial resection of hepatoce
✍ David Fuks; Safi Dokmak; ValΓ©rie Paradis; Momar Diouf; FranΓ§ois Durand; Jacques πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 344 KB πŸ‘ 1 views

Liver resection (LR) for hepatocellular carcinoma (HCC) as the first-line treatment in transplantable patients followed by ''salvage transplantation'' (ST) in case of recurrence is an attractive concept. The aim was to identify patients who gain benefit from this approach in an intention-to-treat st

Cancer survival in Germany and the Unite
✍ Adam Gondos; Volker Arndt; Bernd Holleczek; Christa Stegmaier; Hartwig Ziegler; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 228 KB

## Abstract Transatlantic cancer survival comparisons are scarce and involve mostly aggregate European data from the late 1980s. We compare the levels of cancer patient survival achieved in Germany and the United States (US) by the beginning of the 21st century, using data from the Cancer Registry